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Background: Obstetric hemorrhage remains the leading cause of maternal mortality in resource limited areas. An
inexpensive pneumatic anti-shock garment was devised of bicycle tubes and tailored cloth which can be prepared
from local materials in resource-limited settings. The main purposes of this study were: 1) to determine acceptability
of the device by nurses and midwives and obtain suggestions for making the device more suitable for use in their
particular work environments, 2) to determine whether a three hour training course provided adequate instruction
in the use of this device for the application of circumferential abdominal pelvic pressure, and 3) determine
production capability and cost in a resource-limited country.
Methods: Fifty-eight nurse and midwife participants took part in three sessions over eight months in Nepal. Correct
device placement was assessed on non-pregnant participants using ultrasound measurement of distal aortic flow
before and after device inflation, and analyzed using confidence intervals. Participants were surveyed to determine
acceptability of the device, obtain suggestions for improvement, and to collect data on clinical use.
Results: Device placement achieved flow decreases with a mean of 39% (95% CI 25%-53%, p < 0.001) in the first
session, 28% (95% CI 21%-33%, P < 0.001) after four months and 29% (95% CI 24%-34%, p < 0.001) at 8 months. All
nurses and midwives thought the device would be acceptable for use in obstetric hemorrhage and that they could
make, clean, and apply it. They quickly learned to apply the device, remembered how to apply it, and were willing
and able to use the device clinically. Ten providers used the device, each on one patient, to treat obstetric
hemorrhage after routine measures had failed; bleeding stopped promptly in all ten, two of whom were
transported to the hospital. Production of devices in Kathmandu using local tailors and supplies cost approximately
$40 per device, in a limited production setting.
Conclusions: Preliminary data suggest that an inexpensive, easily-made device is potentially an appropriate
addition to current obstetric hemorrhage treatment in resource-limited areas and that further study is warranted.
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Obstetric hemorrhage is the leading cause of maternal
death worldwide, including 33.9% of cases in Africa and
30.8% in Asia [1]. Most cases are postpartum and initial
treatment includes uterotonic medications such as oxyto-
cin and misoprostol plus bimanual massage. However, in
rural and remote areas, these drugs are often not available.
When bleeding is not due to atony or is not responsive to
these interventions, other approaches are needed. Treat-
ment is most effective when initiated promptly, so it needs
to be readily available at the birth site – which in many
resource-limited areas is the home or a small clinic. Aortic
compression is an age-old method for treatment of obste-
tric hemorrhage (or pelvic trauma) using an open hand,
fist, or knee to compress the aorta against the underlying
lumbar vertebrae [2,3]. Prolonged compression is difficult,
however, when personnel are limited or other interven-
tions or transport are needed. Anti-shock garments pro-
vide circumferential abdominal-pelvic pressure (CAPP),
which incorporates the essence of aortic compression.
They can be pneumatic (inflatable) anti-shock garments
(PASG) or non-inflatable anti-shock garments (NASG) in
design. Their use for postpartum hemorrhage is not new
and there are numerous case reports of successful
use of PASG and NASG for obstetric and post-opera-
tive hemorrhage [4]. Two pre-intervention/intervention
trials with NASG showed improved maternal outcomes
[5]. A cluster randomized trial of NASG for obstetrical
hemorrhage was promising although it did not reach
statistical significance [6].
Pneumatic anti-shock garments (also called Military or
Medical Anti-Shock Trousers) were developed in the
early 1900’s to treat shock in surgical and battlefield
patients. They were used extensively to treat trauma
patients in the United States until the mid-1980’s, when
studies revealed slightly decreased survival rates in a
population of urban pre-hospital trauma patients with
quick transport to a trauma center and suffering prima-
rily from injuries above the pelvis [7]. To some degree
the term “anti-shock” may be a misnomer because the
devices only squeeze about 250 ml of blood from the
pelvis and legs to the upper body [8]. However, they do
greatly decrease pelvic perfusion by delivering direct
pressure to pelvic compartment organs and to smaller
pelvic blood vessels. Commercial pneumatic anti-shock
garments have been shown to decrease distal aortic
blood flow by up to 90% [9] at the level of the superior
mesenteric artery. The NASG was shown to decrease
distal aortic blood flow by about one-third (34%) [10].
PASG and NASG can be used while additional treatment
is being performed or prepared for and can provide de-
finitive treatment in some cases if they provide complete
hemostasis. PASG are extremely safe, with an estimated
complication rate of less than one per 100,000 cases[11]. Unfortunately, commercial PASG are relatively
expensive and both devices are bulky and relatively diffi-
cult to clean. We believe that there is a need for an inex-
pensive aortic compression/anti-shock device that can
be made almost anywhere in the world and be easily
available at all births, at home or in a health care facility.
We therefore designed a new PASG which can be im-
provised on the spot from bicycle tubes and cloth sheets,
or prepared in advance by a local tailor or seamstress.
We elected to call this a CAPP (circumferential abdom-
inal-pelvic pressure) device to clarify its mechanism of
action and differentiate it from commercial PASGs. Our
prototype CAPP device utilized three bicycle tubes, one
placed over each leg and one coiled on the lower abdo-
men; each was then tightly over-wrapped with bed
sheets and secured with adhesive tape. We found that,
when applied by physicians on healthy non-pregnant
volunteers in the United States, this device decreased
distal aortic blood flow by over half (56%) [10].
Nepal was selected for several reasons. The overall
maternal mortality rate is high, at 240 per 100,000 live
births (uncertainty interval 149–370) in 2008 [12]. The
percentage of births attended by a skilled provider is low
(36%), and the percentage of deliveries occurring in a
facility (hospital, primary health center, health post or
sub-health post) was only 28% during the five years prior
to the 2011 Demographic Health Survey [13]. At health
and sub-health posts births are attended by nurses or
midwives (auxiliary nurse midwives) and surgery and
blood transfusion are not available. Midwives are also
called upon to attend home deliveries, particularly when
problems occur. Transportation of patients is difficult in
Nepal due to topography and lack of infrastructure. Nurses
perform the majority of in-hospital uncomplicated vaginal
deliveries in Nepal. Nurses receive 36 months of nursing
education after 12 years of basic education. Auxiliary nurse
midwives receive 18 or 24 months of training after at least
8 years of basic education.
During preliminary discussions at Dhulikhel Hospital,
Kathmandu University School of Medical Sciences in
2010, staff nurses suggested that modification was
needed to expedite application by practitioners working
“solo” in small facilities and homes. Accordingly, the
current study used a modified device with tailored ab-
dominal and leg compartments with pockets to contain
the bicycle tubes, which are inflated with a bicycle pump
after the compartments are secured in place (Figures 1
and 2). The final version was further modified to include
utilized hook-and-loop strips (Velcro™) for closure in-
stead of tape (Figure 3). All components, including
fabric, bicycle tubes and pumps, were purchased in
Kathmandu and tailored locally. Total cost per device
was approximately US $40, of which about half was for
the pump and bicycle tubes. The device’s cloth elements
Figure 1 CAPP device tailored from sheet material; pockets contain each bicycle tube, inflated.
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parts washed or cleaned by soaking in mild bleach
solution.
Diffusion of innovative devices and treatments can be
difficult and slow unless they meet a clear need for the
intended user, are relatively easy to obtain and use, and are
culturally acceptable [14]. The objectives of the current
study were to determine whether obstetrics providers in a
resource-limited setting believe this inexpensive tailored
CAPP device would be clinically useful and acceptable,
and whether they would be willing and able to use it.
Methods
The study was done over three sessions at Kathmandu
University during August 2011, November 2011 and
April 2012. The first was primarily a training session inFigure 2 Class demonstration of device application with nurses and muse of the CAPP device. The second and third were pri-
marily evaluative and intended to elicit attitudes and
measure skill maintenance over time.
The study enrolled 58 participants including nurses and
midwives in Kavre and neighboring districts, who repre-
sented a cross-section of non-physician skilled birth atten-
dants. Midwives were recruited from a variety of small
health facilities including sub-health posts. Many came
from rural areas that were up to a two days’ walk from the
nearest road. We attempted to include representatives
from the various kinds of facilities available to pregnant
women in Nepal. Inclusion criteria were all active mid-
wives and all nurses who had completed Skilled Birth
Attendant (SBA) training and were hence eligible to
provide midwifery services. Participants were randomly
selected by name from all the 344 primary health posts,idwives.
Figure 3 CAPP device with hook-and-loop (Velcro™) on
abdominal and leg pieces.
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area for Kathmandu University Dhulikhel Hospital. This
hospital, which is the de facto district hospital for Kavre
District also serves as the obstetric tertiary care center
for four neighboring rural districts: Sindhupoalchowk,
Dolakha, Ramechhap and Sindhuli. Midwives and nurses
were contacted through the appropriate District Health
Office which is the governing body for health for each
district. Ramechhap District Hospital refers tertiary care
obstetric patients to Dhulikhel Hospital and there is one
small private hospital slightly closer to Kathmandu, Scheer
Memorial Hospital, which also serves as a referral facility
for a limited number of obstetric patients. Both hospitals
were included. The number of providers from each facility
was limited to that which could be away from the facility
without impacting patient care, with a goal of recruiting
approximately sixty participants from a representative
variety of facilities. Sixty was the estimated number
needed by the research protocol. Three hospitals, eight
primary health centers, thirteen health posts, nine sub
health posts and two Dhulikhel Hospital outreach centers
were eventually included.Participants received reimbursement for travel, food and
lodging, but were not compensated for their time. Initial
training involved bringing all participants, in five groups
of 10 to 15, to Dhulikhel Hospital. A one hour review
of postpartum hemorrhage management was given in
English and Nepali. The device was demonstrated and
each participant learned to place it on a partner, with a
third participant assisting. It was stressed that the device
was to be used in conjunction with standard methods of
treatment, which generally included oxytocin and/or mi-
soprostol, uterine massage, and manual removal of the
placenta or placental fragments if needed. Detailed infor-
mation about study format and potential risks and bene-
fits of the study were presented. Participants who were
pregnant, had abdominal complaints or declined having it
placed were excluded from having the device used on
upon them, but could place it on others.
Quantitative information was obtained using a written
survey instrument specifically designed to elicit feedback
covering the listed objectives from this study population.
Participants were asked six questions which had yes/
maybe/no response options (reproduced verbatim in
Table 1). One additional, open-ended question: “Do you
have specific concerns or suggestions about the CAPP
device?” elicited qualitative data. This question was first
asked individually using the written form and later dis-
cussed in a small group session to allow “brainstorming”
among participants. The surveys were in English, the
standard language for medical instruction in Nepal, and
each participant also reviewed her responses with a bi-
lingual Nepali obstetrician (SRT) to allow her to clarify
any potentially ambiguous or incomplete responses.
To assess their skill in device placement, the partner’s
distal aortic blood flow below the takeoff of the superior
mesenteric artery was measured using ultrasound, first
at baseline and then with the device inflated. This quan-
titative data was used to confirm that participants had
learned the psychomotor skills needed to use the device
competently.
Participants were given one device “kit”, including tai-
lored cloth pieces, bicycle tubes, and pump. They were
told that they could use the device if they believed it was
needed, but only after all standard treatments had been
initiated.
The assessments were repeated during the second
session at four months post training and during the third
session at eight months. Each participant again used the
device on a partner and placement was assessed by ultra-
sound measurement of distal aortic flow. The same basic
survey was administered (Table 1), and those who had used
the device clinically were individually given an additional
“clinical use” survey that asked about the circumstances
and outcome and was followed by a personal interview
with a Nepali-speaking physician-researcher (SRT).
Table 1 Participant attitudes toward the CAPP device across three training sessions
Session 1 Session 2 (4 mo.) Session 3 (8 mo.)
n = 58 n = 51 n = 50
Yes Maybe No Yes Maybe No Yes Maybe No
Do you feel comfortable that you could successfully apply the CAPP device? 58 0 0 50 1a 0 50 0 0
Do you think that the CAPP device would help treat postpartum hemorrhage? 58 0 0 51 0 0 ** ** **
If you had the CAPP device would you use it to help treat postpartum hemorrhage? 58 0 0 51 0 0 50 0 0
Do you think that you could successfully clean a CAPP device? 58 0 0 51 0 0 ** ** **
Would you make a CAPP device if plans were available? 58 0 0 51 0 0 ** ** **
Have you used a CAPP device clinically on a patient? * * * 9 * 42 10b * 40
*Not applicable.
**Not asked.
aOne provider thought she would need help from “the patient’s sister”.
bIncludes the 9 patients at 4 months.
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the first session. At the four month session, fifty one
participants returned. Of the seven participants who did
not return, one who had been pregnant had delivered,
one left the district for further education, two needed to
attend to ill family members, and three were from a dis-
tant health-post that could not be contacted. Fifty par-
ticipants returned at eight months; the one who did not
return had delivered in the interim.
The University of New Mexico’s Institutional Review
Board (IRB) ruled this study exempt under Federal Regu-
lation 45CFR46.101(b) on 6/30/2010 (HRC #10-229) and
approval for this study was obtained from the IRB of
Kathmandu University School of Medical Sciences in
Dhulikhel, Nepal on 6/24/2011 (#11-11). Studies of educa-
tional methodology do not require written informed con-
sent and it was not required by either IRB. Participants
were free to opt out of the educational program or to quit
at any time. There was no direct benefit to them for par-
ticipating and there was no disadvantage to withdrawal.
All participants did provide written consent to be photo-
graphed for the figures.
Although this study was not a clinical trial it was re-
gistered at clinicaltrials.gov (identifier: NCT01497756) to
track any complications or adverse events occurring with
clinical use of the CAPP device. PASG are an approved
treatment modality classified as pre-amendment devices
under FDA regulations and have been extensively mar-
keted and used for pelvic bleeding, so it was deemed to be
impossible and unethical to prohibit use as a last resort in
the clinical setting. However, the researchers and IRBs felt
that failure to track clinical use would potentially put fu-
ture patients at risk if complications were not identified
and reported.
Measurements of aortic flow were recorded on paper
and electronic memory cards from the ultrasound ma-
chines (SonoSite MicroMaxx™). Data were transferred
using a double data entry format to an Excel™ (Microsoft
Corporation, Redmond WA) spreadsheet. The decrease indistal aortic flow was calculated using Excel™. Stata 11®
(StataCorp LP, College Station, Texas) was used for sta-
tistical analysis. Survey data were recorded numerically
when possible and descriptively when appropriate.
Results
At the initial training the mean reduction in distal aortic
flow with application of the device was 39% (95%
CI 25% - 53%, P < 0.001). At the four month session
mean blood flow reduction was 28% (95 CI 21% - 33%,
P < 0.001). At the eight month session mean distal aortic
flow reduction was 29% (95% CI 24% - 34%, P < 0.001).
Upon being surveyed, all participants believed they
were capable of tailoring, assembling, and cleaning the
device and that it would be helpful for treatment of
postpartum hemorrhage patients. All participants be-
lieved they could successfully apply it alone, but one
thought she would need help from “the patient’s sister”.
Ten participants, all from health or sub-health posts,
used the device clinically, each on a single patient.
Bleeding promptly stopped and all ten patients had good
outcomes. There were no adverse effects except that one
patient requested prompt removal of the device after her
bleeding stopped because of leg pain. Two patients were
transported with the device in place to a hospital for fur-
ther care, one for a massive vulvar-vaginal hematoma
and another for a delayed postpartum hemorrhage ten
days post-delivery.
Participants made several suggestions for modification
of the device. In response, an additional small group com-
pared a 20 cm diameter inflatable ball (standard soccer
ball size) to the bicycle tube as the inflatable portion of
the abdominal piece. They noted the ball to be quicker
and easier to place and inflate than the bicycle tube, and
more comfortable for the wearer.
Discussion
The three devices that apply circumferential abdominal-
pelvic pressure have different potential advantages and
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cord of successful use by minimally trained personnel as
well as physicians [11]. The device is considerably better
at decreasing pelvic blood flow than the alternatives [9].
It seems logical that commercial PASG be used in hos-
pital facilities for management of obstetric hemorrhage
to acutely decrease blood loss while resuscitating the pa-
tient. This would allow more aggressive options such as
uterine artery embolization, laparotomy with hemostatic
sutures or hysterectomy, if still needed, to be done on a
more stable patient. However, commercial PASG are
relatively expensive, complex in design and manufacture,
difficult to repair and awkward to clean. This makes
them less suitable for smaller facilities in low resource
settings.
NASG are much less effective at decreasing pelvic per-
fusion [10] but are less expensive. They are the least
complex of the three devices. Manufacture and repair
are considerably easier than for commercial PASG al-
though they still require specialized supplies and equip-
ment. They are also easier to clean than commercial
PASG. They are made of neoprene which degrades very
slowly when stored but much more rapidly in the pres-
ence of petroleum products or bleach. NASG have been
successfully used to treat obstetric hemorrhage in low
resource environments [5].
Our CAPP/non-commercial PASG device is more ef-
fective at decreasing pelvic perfusion than NASG but less
effective than commercial PASG [10]. It is easy to clean. It
is as complex in design as the commercial PASG but can
be made and repaired by anyone with a sewing machine
and access to suitable cloth, tape or hook and loop clo-
sures, bicycle tubes and a pump. Local production can
contribute to local economies and open opportunities for
locally organized trainings and social marketing. Birth
attendants can potentially make their own. It is the least
expensive of the three devices and its modular design
allows for replacement of individual parts if necessary.
These characteristics mean that this CAPP device poten-
tially has a much shorter supply chain than the other de-
vices and that it can be easily replaced if, for example, it is
used on a patient who is transported to distant facility.
The pressure in both our device and in commercial PASG
can be varied while they are being used, making it possible
for the provider to titrate pressure as needed to control
hemorrhage while minimizing discomfort.
All three devices are easy to use and require minimal
training. They all work – i.e. they decrease pelvic blood
flow. They are all safe – even the 90% decrease in pelvic
blood flow from commercial PASG is tolerated well and
is associated with an extraordinarily low complication
rate. Given that obstetric hemorrhage is to a large degree
unpredictable, treatment is most effective before compli-
cations occur, and the devices are very safe, it seems bestto have them available at every birth, including home
births, so that early application is possible. In facilities
with a high volume of deliveries, an adequate supply of
devices would allow them to be used more frequently
and earlier before hemorrhage becomes severe and
shock ensues.
There are limitations to this study. The CAPP device
was applied to healthy, non-pregnant women who were
not immediately postpartum, volume depleted, or in
hemorrhagic shock, and therefore the decreases in flow
may not be predictive of absolute flow change in patients
with obstetric hemorrhage. Blood flow in the distal aorta
is not identical to uterine artery flow. Additionally, the
optimal amount of blood flow reduction is not known
and is unlikely to be the same for all patients. The study
was not designed to directly evaluate patient accepta-
bility or clinical effectiveness.
Conclusions
In summary, nurses and midwives in Nepal were quickly
able to learn to use an inexpensive CAPP/non-commercial
PASG device with the educational methodology presented
and were enthusiastic about its use. They believed that
they could make and maintain the device themselves. Par-
ticipants were able to decrease distal aortic flow in healthy
non-pregnant volunteers by about one third, with signifi-
cant changes persisting for at least eight months after
training. The limited clinical experience was uniformly
positive. Our preliminary data suggest that this device is
likely to be at least as effective as NASG and can be easily
made inexpensively in a resource-limited country. Devices
which decrease pelvic perfusion complement other me-
thods for treatment of obstetric hemorrhage and may fa-
cilitate transport of the patient to a higher level of care in
more stable condition.
We believe that this inexpensive CAPP device is a po-
tentially valuable addition to management options for
obstetric hemorrhage and propose that further study be
done to assess its clinical efficacy as an addition to inte-
grated strategies for decreasing maternal mortality [15].
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